Skip to main content

Ortho Evra News

Related terms: Evra Patch

Mylan Launches Xulane - First Generic Ortho Evra Patch

PITTSBURGH, April 16, 2014 /PRNewswire/ – Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Xulane (Norelgestromin / Ethinyl Estradiol...

FDA Medwatch Alert: Qualitest Pharmaceuticals Oral Contraceptives: Recall - Packaging Error

includes Cyclafem 7/7/7, Cyclafem 1/35, Emoquette, Gildess FE 1.5/30, Gildess FE 1/20, Orsythia, Previfem, Tri-Previfem ISSUE: Qualitest Pharmaceuticals issued a nationwide, retail-level recall of...

FDA Medwatch Alert: Ortho Evra Contraceptive Transdermal Patch

[Posted 01/19/2008] FDA modified the prescribing information for the Ortho Evra Contraceptive Transdermal (Skin) Patch to include the results of a new epidemiology study that found that users of the...

FDA Medwatch Alert: Ortho Evra (norelgestromin/ethinyl estradiol)

[Posted 09/20/2006] Ortho-McNeil and FDA notified healthcare professionals and patients about revisions to the prescribing information to inform them of the results of two separate epidemiology...

FDA Medwatch Alert: Ortho Evra (norelgestromin/ethinyl estradiol transdermal system)

[Posted 11/14/2005] FDA notified healthcare professionals and patients of revisions to the label for Ortho Evra, a skin patch approved for birth control, that includes a bolded warning about...

FDA Medwatch Alert: Counterfeit contraceptive patches

FDA and Johnson and Johnson Co. of Raritan, NJ are warning the public about an overseas internet site selling counterfeit contraceptive patches that contain no active ingredients.The counterfeit...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Ortho Evra patient information at Drugs.com